Predictors and prognostic value of myocardial injury during transcatheter aortic valve implantation

Circulation: Cardiovascular Interventions

Volumn 5, Issue 3, 2012, Pages 415-423

  Yong, Ze Yie ^a   Wiegerinck, Esther M A ^a   Van Dijk, Kirsten Boerlage ^a   Koch, Karel T ^a   Vis, Marije M ^a   Bouma, Berto J ^a   Henriques, José P S ^a   Cocchieri, Riccardo ^a   Piek, Jan J ^a   De Mol, Bas A J M ^a   Baan, Jan ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Aortic valve stenosis; Creatine kinase MB; Ischemia; Transcatheter aortic valve implantation; Troponin T

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATINE KINASE MB; TROPONIN T;

AGED; AORTA VALVE PROSTHESIS; AORTA VALVE STENOSIS; ARTICLE; CARDIOVASCULAR MORTALITY; ENZYME BLOOD LEVEL; FEMALE; HEART LEFT VENTRICLE MASS; HEART MUSCLE INJURY; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TRANSCATHETER AORTIC VALVE IMPLANTATION;

EID: 84864579516     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/CIRCINTERVENTIONS.111.964882     Document Type: Article

References (46)

1. Baan J, Yong ZY, Koch KT, Henriques JP, Bouma BJ, de Hert SG, van der MJ, Tijssen JG, Piek JJ, de Mol BA. Percutaneous implantation of the CoreValve aortic valve prosthesis in patients at high risk or rejected for surgical valve replacement: clinical evaluation and feasibility of the procedure in the first 30 patients in the AMC-UvA. Neth Heart J. 2010; 18:18-24.
2. Berry C, Asgar A, Lamarche Y, Marcheix B, Couture P, Basmadjian A, Ducharme A, Laborde JC, Cartier R, Bonan R. Novel therapeutic aspects of percutaneous aortic valve replacement with the 21F CoreValve Revalving System. Catheter Cardiovasc Interv. 2007;70:610-616.
3. Cribier A, Eltchaninoff H, Tron C, Bauer F, Agatiello C, Nercolini D, Tapiero S, Litzler PY, Bessou JP, Babaliaros V. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol. 2006;47:1214-1223.
4. Grube E, Schuler G, Buellesfeld L, Gerckens U, Linke A, Wenaweser P, Sauren B, Mohr FW, Walther T, Zickmann B, Iversen S, Felderhoff T, Cartier R, Bonan R. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second-and current thirdgeneration self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol. 2007;50:69-76.
5. Marcheix B, Lamarche Y, Berry C, Asgar A, Laborde JC, Basmadjian A, Ducharme A, Denault A, Bonan R, Cartier R. Surgical aspects of endovascular retrograde implantation of the aortic CoreValve bioprosthesis in high-risk older patients with severe symptomatic aortic stenosis. J Thorac Cardiovasc Surg. 2007;134:1150-1156.
6. Webb JG, Pasupati S, Humphries K, Thompson C, Altwegg L, Moss R, Sinhal A, Carere RG, Munt B, Ricci D, Ye J, Cheung A, Lichtenstein SV. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation. 2007;116:755-763.
7. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597-1607.
8. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187-2198.
9. Akkerhuis KM, Alexander JH, Tardiff BE, Boersma E, Harrington RA, Lincoff AM, Simoons ML. Minor myocardial damage and prognosis: are spontaneous and percutaneous coronary intervention-related events different? Circulation. 2002;105:554-556.
10. Gardner SC, Grunwald GK, Rumsfeld JS, Cleveland JC, Jr., Schooley LM, Gao D, Grover FL, McDonald GO, Shroyer AL. Comparison of short-term mortality risk factors for valve replacement versus coronary artery bypass graft surgery. Ann Thorac Surg. 2004;77:549-556.
11. Greenson N, Macoviak J, Krishnaswamy P, Morrisey R, James C, Clopton P, Fitzgerald R, Maisel AS. Usefulness of cardiac troponin I in patients undergoing open heart surgery. Am Heart J. 2001;141:447-455.
12. Ioannidis JP, Karvouni E, Katritsis DG. Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention. J Am Coll Cardiol. 2003;42:1406-1411.
13. Lasocki S, Provenchere S, Benessiano J, Vicaut E, Lecharny JB, Desmonts JM, Dehoux M, Philip I. Cardiac troponin I is an independent predictor of in-hospital death after adult cardiac surgery. Anesthesiology. 2002;97:405-411.
14. Nesher N, Alghamdi AA, Singh SK, Sever JY, Christakis GT, Goldman BS, Cohen GN, Moussa F, Fremes SE. Troponin after cardiac surgery: a predictor or a phenomenon? Ann Thorac Surg. 2008;85:1348-1354.
15. Nienhuis MB, Ottervanger JP, Bilo HJ, Dikkeschei BD, Zijlstra F. Prognostic value of troponin after elective percutaneous coronary intervention: a meta-analysis. Catheter Cardiovasc Interv. 2008;71:318-324.
16. Provenchere S, Berroeta C, Reynaud C, Baron G, Poirier I, Desmonts JM, Iung B, Dehoux M, Philip I, Benessiano J. Plasma brain natriuretic peptide and cardiac troponin I concentrations after adult cardiac surgery: association with postoperative cardiac dysfunction and 1-year mortality. Crit Care Med. 2006;34:995-1000.
17. Simoons ML, van den BM, Lincoff M, Harrington R, van der WR, Vahanian A, Rutsch W, Kootstra J, Boersma E, Califf RM, Topol E. Minimal myocardial damage during coronary intervention is associated with impaired outcome. Eur Heart J. 1999;20:1112-1119.
18. Testa L, Van Gaal WJ, Biondi Zoccai GG, Agostoni P, Latini RA, Bedogni F, Porto I, Banning AP. Myocardial infarction after percutaneous coronary intervention: a meta-analysis of troponin elevation applying the new universal definition. QJM. 2009;102:369-378.
19. Braathen B, Tonnessen T. Cold blood cardioplegia reduces the increase in cardiac enzyme levels compared with cold crystalloid cardioplegia in patients undergoing aortic valve replacement for isolated aortic stenosis. J Thorac Cardiovasc Surg. 2010;139:874-880.
20. Di SS, Casquero E, Bustamante R, Gualis J, Carrascal Y, Bustamante J, Fulquet E, Florez S, Echevarria JR, Fiz L. Plasma troponins as markers of myocardial damage during cardiac surgery with extracorporeal circulation. Tohoku J Exp Med. 2007;213:63-69.
21. Etievent JP, Chocron S, Toubin G, Taberlet C, Alwan K, Clement F, Cordier A, Schipman N, Kantelip JP. Use of cardiac troponin I as a marker of perioperative myocardial ischemia. Ann Thorac Surg. 1995; 59:1192-1194.
22. Katus HA, Schoeppenthau M, Tanzeem A, Bauer HG, Saggau W, Diederich KW, Hagl S, Kuebler W. Non-invasive assessment of perioperative myocardial cell damage by circulating cardiac troponin T. Br Heart J. 1991;65:259-264.
23. Strom S, Bendz R, Olin C. Myocardial injury and CK-MB release during aortic valve surgery with selective coronary perfusion. Clin Cardiol. 1981;4:155-161.
24. Luo W, Li B, Chen R, Huang R, Lin G. Effect of ischemic postconditioning in adult valve replacement. Eur J Cardiothorac Surg. 2008;33: 203-208.
25. Weman SM, Karhunen PJ, Penttila A, Jarvinen AA, Salminen US. Reperfusion injury associated with one-fourth of deaths after coronary artery bypass grafting. Ann Thorac Surg. 2000;70:807-812.
26. Bose D, von BC, Zhou XY, Schmermund A, Philipp S, Sack S, Konorza T, Mohlenkamp S, Leineweber K, Kleinbongard P, Wijns W, Heusch G, Erbel R. Impact of atherosclerotic plaque composition on coronary microembolization during percutaneous coronary interventions. Basic Res Cardiol. 2008;103:587-597.
27. Herrmann J. Peri-procedural myocardial injury: 2005 update. Eur Heart J. 2005;26:2493-2519.
28. Grube E, Laborde JC, Gerckens U, Felderhoff T, Sauren B, Buellesfeld L, Mueller R, Menichelli M, Schmidt T, Zickmann B, Iversen S, Stone GW. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg firstin-man study. Circulation. 2006;114:1616-1624.
29. Leon MB, Piazza N, Nikolsky E, Blackstone EH, Cutlip DE, Kappetein AP, Krucoff MW, Mack M, Mehran R, Miller C, Morel MA, Petersen J, Popma JJ, Takkenberg JJ, Vahanian A, van Es GA, Vranckx P, Webb JG, Windecker S, Serruys PW. Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol. 2011;57: 253-269.
30. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57:450-458.
31. Wenaweser P, Pilgrim T, Roth N, Kadner A, Stortecky S, Kalesan B, Meuli F, Bullesfeld L, Khattab AA, Huber C, Eberle B, Erdos G, Meier B, Juni P, Carrel T, Windecker S. Clinical outcome and predictors for adverse events after transcatheter aortic valve implantation with the use of different devices and access routes. Am Heart J. 2011;161:1114-1124.
32. Rodes-Cabau J, Gutierrez M, Bagur R, De Larochelliere R, Doyle D, Cote M, Villeneuve J, Bertrand OF, Larose E, Manazzoni J, Pibarot P, Dumont E. Incidence, predictive factors, and prognostic value of myocardial injury following uncomplicated transcatheter aortic valve implantation. J Am Coll Cardiol. 2011;57:1988-1999.
33. Licker M, Sierra J, Kalangos A, Panos A, Diaper J, Ellenberger C. Cardioprotective effects of acute normovolemic hemodilution in patients with severe aortic stenosis undergoing valve replacement. Transfusion. 2007;47:341-350.
34. Swaanenburg JC, Loef BG, Volmer M, Boonstra PW, Grandjean JG, Mariani MA, Epema AH. Creatine kinase MB, troponin I, and troponin T release patterns after coronary artery bypass grafting with or without cardiopulmonary bypass and after aortic and mitral valve surgery. Clin Chem. 2001;47:584-587.
35. Pichon H, Chocron S, Alwan K, Toubin G, Kaili D, Falcoz P, Latini L, Clement F, Viel JF, Etievent JP. Crystalloid versus cold blood cardioplegia and cardiac troponin I release. Circulation. 1997;96:316-320.
36. Fuster RG, Argudo JA, Albarova OG, Sos FH, Lopez SC, Sorli MJ, Codoner MB, Minano JA. Left ventricular mass index in aortic valve surgery: a new index for early valve replacement? Eur J Cardiothorac Surg. 2003;23:696-702.
37. Nemes A, Forster T, Varga A, Vass A, Borthaiser A, Palinkas A, Csanady M. How can coronary flow reserve be altered by severe aortic stenosis? Echocardiography. 2002;19:655-659.
38. Akasaka T, Yoshida K, Hozumi T, Takagi T, Kaji S, Kawamoto T, Ueda Y, Okada Y, Morioka S, Yoshikawa J. Restricted coronary flow reserve in patients with mitral regurgitation improves after mitral reconstructive surgery. J Am Coll Cardiol. 1998;32:1923-1930.
39. Ardehali A, Segal J, Cheitlin MD. Coronary blood flow reserve in acute aortic regurgitation. J Am Coll Cardiol. 1995;25:1387-1392.
40. Wang FW, Osman A, Otero J, Stouffer GA, Waxman S, Afzal A, Anzuini A, Uretsky BF. Distal myocardial protection during percutaneous coronary intervention with an intracoronary beta-blocker. Circulation. 2003;107:2914-2919.
41. Uretsky BF, Birnbaum Y, Osman A, Gupta R, Paniagua O, Chamoun A, Pohwani A, Lui C, Lev E, McGehee T, Kumar D, Akhtar A, Anzuini A, Schwarz ER, Wang FW. Distal myocardial protection with intracoronary beta blocker when added to a Gp IIb/IIIa platelet receptor blocker during percutaneous coronary intervention improves clinical outcome. Catheter Cardiovasc Interv. 2008;72:488-497.
42. Baan J, Jr., Yong ZY, Koch KT, Henriques JP, Bouma BJ, Vis MM, Cocchieri R, Piek JJ, de Mol BA. Factors associated with cardiac conduction disorders and permanent pacemaker implantation after percutaneous aortic valve implantation with the CoreValve prosthesis. Am Heart J. 2010;159:497-503.
43. Dehoux M, Provenchere S, Benessiano J, Lasocki S, Lecharny JB, Bronchard R, Dilly MP, Philip I. Utility of cardiac troponin measurement after cardiac surgery. Clin Chim Acta. 2001;311:41-44.
44. Buellesfeld L, Wenaweser P, Gerckens U, Mueller R, Sauren B, Latsios G, Zickmann B, Hellige G, Windecker S, Grube E. Transcatheter aortic valve implantation: predictors of procedural success-the Siegburg-Bern experience. Eur Heart J. 2010;31:984-991.
45. Mehta RH, Bruckman D, Das S, Tsai T, Russman P, Karavite D, Monaghan H, Sonnad S, Shea MJ, Eagle KA, Deeb GM. Implications of increased left ventricular mass index on in-hospital outcomes in patients undergoing aortic valve surgery. J Thorac Cardiovasc Surg. 2001;122: 919-928.
46. Orsinelli DA, Aurigemma GP, Battista S, Krendel S, Gaasch WH. Left ventricular hypertrophy and mortality after aortic valve replacement for aortic stenosis: a high risk subgroup identified by preoperative relative wall thickness. J Am Coll Cardiol. 1993;22:1679-1683.